Ekram Saleh

872 total citations
24 papers, 653 citations indexed

About

Ekram Saleh is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ekram Saleh has authored 24 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Ekram Saleh's work include Cancer therapeutics and mechanisms (8 papers), DNA Repair Mechanisms (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Ekram Saleh is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), DNA Repair Mechanisms (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Ekram Saleh collaborates with scholars based in Egypt, United Arab Emirates and Germany. Ekram Saleh's co-authors include Raafat El‐Awady, Wafaa S. Ramadan, Varsha Menon, Nehal Soliman, Rania Harati, Hussain Alawadhi, Wolfram‐Hubertus Zimmermann, Abdel Hady A. Abdel Wahab, Jochen Dahm‐Daphi and Cijo George Vazhappilly and has published in prestigious journals such as International Journal of Molecular Sciences, Toxicology and Applied Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Ekram Saleh

24 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ekram Saleh Egypt 16 395 153 98 86 54 24 653
Ragu Kanagasabai United States 15 388 1.0× 120 0.8× 41 0.4× 88 1.0× 32 0.6× 22 576
Mohammad Sarwar Jamal Saudi Arabia 19 467 1.2× 203 1.3× 136 1.4× 71 0.8× 130 2.4× 37 992
Peng Lyu China 11 422 1.1× 104 0.7× 122 1.2× 35 0.4× 70 1.3× 30 767
Iman W. Achkar Qatar 10 434 1.1× 149 1.0× 124 1.3× 46 0.5× 65 1.2× 12 751
Lisa Gruber Germany 17 319 0.8× 68 0.4× 74 0.8× 72 0.8× 70 1.3× 21 677
Zhiling Li China 10 255 0.6× 132 0.9× 75 0.8× 26 0.3× 56 1.0× 25 726
Marianna G. Yakubovskaya Russia 18 572 1.4× 143 0.9× 74 0.8× 74 0.9× 82 1.5× 83 863
Babajan Banaganapalli Saudi Arabia 18 381 1.0× 57 0.4× 83 0.8× 64 0.7× 90 1.7× 60 751
Yongping Zhu China 13 247 0.6× 66 0.4× 59 0.6× 96 1.1× 66 1.2× 36 594
Mann-Jen Hour Taiwan 13 355 0.9× 76 0.5× 70 0.7× 279 3.2× 42 0.8× 17 673

Countries citing papers authored by Ekram Saleh

Since Specialization
Citations

This map shows the geographic impact of Ekram Saleh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekram Saleh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekram Saleh more than expected).

Fields of papers citing papers by Ekram Saleh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekram Saleh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekram Saleh. The network helps show where Ekram Saleh may publish in the future.

Co-authorship network of co-authors of Ekram Saleh

This figure shows the co-authorship network connecting the top 25 collaborators of Ekram Saleh. A scholar is included among the top collaborators of Ekram Saleh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekram Saleh. Ekram Saleh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramadan, Wafaa S., Maha Saber-Ayad, Ekram Saleh, et al.. (2023). Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives. iScience. 27(1). 108659–108659. 3 indexed citations
2.
Ramadan, Wafaa S., et al.. (2023). Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. Annals of Medicine. 55(1). 2203946–2203946. 15 indexed citations
3.
Ramadan, Wafaa S., et al.. (2022). The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention. International Journal of Molecular Sciences. 23(15). 8141–8141. 35 indexed citations
4.
Saleh, Ekram, et al.. (2022). Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?. Frontiers in Pharmacology. 13. 938471–938471. 19 indexed citations
5.
Saleh, Ekram, et al.. (2021). Recent advances in management of COVID-19: A review. Biomedicine & Pharmacotherapy. 143. 112107–112107. 58 indexed citations
6.
El‐Awady, Raafat, Ekram Saleh, Rifat Hamoudi, et al.. (2021). Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents. Bioorganic & Medicinal Chemistry. 42. 116251–116251. 10 indexed citations
7.
Ramadan, Wafaa S., Ekram Saleh, Varsha Menon, et al.. (2020). Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate–4-thiazolinone hybrid derivatives. Biomedicine & Pharmacotherapy. 131. 110571–110571. 23 indexed citations
8.
Ramadan, Wafaa S., Cijo George Vazhappilly, Ekram Saleh, et al.. (2018). Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy. Cancers. 11(1). 13–13. 24 indexed citations
9.
Vazhappilly, Cijo George, Ekram Saleh, Wafaa S. Ramadan, et al.. (2018). Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types. Investigational New Drugs. 37(2). 252–261. 30 indexed citations
10.
El‐Awady, Raafat, et al.. (2017). The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy. Frontiers in Pharmacology. 7. 535–535. 113 indexed citations
11.
Saleh, Ekram, et al.. (2017). Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin. Cancer Biology & Therapy. 19(1). 25–33. 70 indexed citations
12.
Tarazi, Hamadeh, Ekram Saleh, & Raafat El‐Awady. (2016). In-silico screening for DNA-dependent protein kinase (DNA-PK) inhibitors: Combined homology modeling, docking, molecular dynamic study followed by biological investigation. Biomedicine & Pharmacotherapy. 83. 693–703. 7 indexed citations
13.
Saleh, Ekram. (2015). Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair. Tumor Biology. 36(11). 8985–8992. 7 indexed citations
14.
El‐Awady, Raafat, Fatema Hersi, Ekram Saleh, et al.. (2015). Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy. Cancer Biology & Therapy. 16(7). 1056–1070. 42 indexed citations
15.
Saleh, Ekram, et al.. (2012). Antagonism between curcumin and the topoisomerase II inhibitor etoposide. Cancer Biology & Therapy. 13(11). 1058–1071. 30 indexed citations
16.
17.
El‐Awady, Raafat, et al.. (2011). Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells. Toxicology and Applied Pharmacology. 255(3). 271–286. 32 indexed citations
18.
El‐Awady, Raafat, Ekram Saleh, & Jochen Dahm‐Daphi. (2010). Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?. Anti-Cancer Drugs. 21(3). 277–287. 23 indexed citations
19.
Saleh, Ekram, et al.. (2009). Altered Expression of Proliferation-Inducing and Proliferation-Inhibiting Genes Might Contribute to Acquired Doxorubicin Resistance in Breast Cancer Cells. Cell Biochemistry and Biophysics. 55(2). 95–105. 19 indexed citations
20.
El‐Awady, Raafat, et al.. (2005). No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients. International Journal of Radiation Biology. 81(7). 501–508. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ragu Kanagasabai Breakdown of academic impact, for papers by Mohammad Sarwar Jamal Breakdown of academic impact, for papers by Peng Lyu Breakdown of academic impact, for papers by Iman W. Achkar Breakdown of academic impact, for papers by Lisa Gruber Breakdown of academic impact, for papers by Zhiling Li Breakdown of academic impact, for papers by Marianna G. Yakubovskaya Breakdown of academic impact, for papers by Babajan Banaganapalli Breakdown of academic impact, for papers by Yongping Zhu Breakdown of academic impact, for papers by Mann-Jen Hour
Rankless by CCL
2026